Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer

Despite improvements in surgery and medical treatments, epithelial ovarian cancer (EOC) remains the most lethal gynaecological malignancy. Aim of this study is to investigate the preclinical immunotherapy activity of cytokine-induced killer lymphocytes (CIK) against epithelial ovarian cancers, focus...

Descripción completa

Detalles Bibliográficos
Autores principales: Capellero, S., Erriquez, J., Melano, C., Mesiano, G., Genta, S., Pisacane, A., Mittica, G., Ghisoni, E., Olivero, M., Di Renzo, M. F., Aglietta, M., Sangiolo, D., Valabrega, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160190/
https://www.ncbi.nlm.nih.gov/pubmed/32296104
http://dx.doi.org/10.1038/s41598-020-63634-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160190/
https://www.ncbi.nlm.nih.gov/pubmed/32296104
http://dx.doi.org/10.1038/s41598-020-63634-z

Ejemplares similares